Adir Et Compagnie

Les Laboratoires Servier

Serge Simonet

Tony Verbeuren

Gilbert Lavielle

Alain Rupin

Bernard Cimetiere

Guillaume De Nanteuil

Jean-Jacques Descombes

Michel Laubie

Bernard Portevin

Philippe Gloanec

Christine Lila

Christophe Thurieau

Thierry Dubuffet

Jean-Luc Fauchere

Christine Vayssettes-Courchay

Christine Courchay

Olivier Muller

Alexis Cordi

Yves Rolland

Alain Benoist

Jean-Gilles Parmentier

Angela D Morris

Danielle Gree

Laure Haberkorn

Ren E Gree

Ali M Hachem

Yves Le Floc'h

Compounds of formula (I): wherein: Medicinal products containing the same which are useful in treating hypertension and cardiovascular pathologies.

Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I):(A)&#xb7;(B)&#x2003;&#x2003;(I)wherein A represents an angiotensin-converting enzyme inhibitor compound containing at least one salt-forming basic function, B represents a compound containing at least one salt-forming acid function and at least one NO donor group, m represents the number of acid functions of B that have been converted to a salt and n represents the number of basic functions of A that have been converted to a salt,the bond or bonds between A and B being of the ionic type. Medicinal products containing the same which are useful in treating cardiovascular pathologies.

Addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them

Benzenesulphonamide compounds

Benzenesulfonamide compounds

Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists

Benzenesulfonylamine compounds, process for preparing them and

Compound of formula (I) ##STR1## in which: R.sub.1 and R.sub.2, which are identical or different, represent hydrogen or alkyl or alternatively R.sub.1 and R.sub.2 form, with the carbon atom which bears them, cycloalkyl,

Compounds derived from boronic acid

Peptide compounds which are therapeutically active in the cascade of

A compound selected from those of formula (I): ##STR1## wherein A, X, Y, Z, R, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined in the description. This compound or its physiologically tolerable salts may be used therapeutically as platelet anti-aggregation agent.

Cyclised analogues of fatty acid metabolites

The invention relates to the compounds of formula (I): ##STR1## in which: R.sub.1 denotes hydrogen, acyl, alkoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl or linear or branched C.sub.1 -C.sub.6 alkyl, substituted or unsubstituted, or R.sub.6 SO.sub.2 -- in which R.sub.6 denotes alkyl, naphthyl, phenyl, benzyl or morpholine,

Peptide compounds derived from boronic acid

The invention relates to peptide compounds of formula (I):

Peptide compounds active in cell adhesion processes

##STR1## in which: R.sub.1 and R.sub.2, which may be identical or different, represent hydrogen or halogen, alkyl, substituted or unsubstituted phenyl, benzyl, pyridylmethyl or imidazolylmethyl or thiazolylmethyl, pyridyl, imidazolyl or thiazolyl, or alternatively,

1,2,3,4-tetrahydronaphthalene compounds

A compound of formula (I): ##STR1## in which: R.sub.1 represents hydrogen or acyl, alkyl, benzyl, alkoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl, 5-[(dimethyl)amino]naphthylsulfonyl, alkoxycarbonylmethyl or carboxymethyl,

Growing community of inventors

Conflans Sainte Honorine, France

Serge Simonet